AOK NORDWEST - THE HEALTH INSURANCE FUND has floated a tender for Open House Contracts for Several Active Ingredients / Active Ingredient Combinations. The project location is Germany and the tender is closing on 01 Aug 2022. The tender notice number is 564276-2020, while the TOT Ref Number is 47830797. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : Germany

Summary : Open House Contracts for Several Active Ingredients / Active Ingredient Combinations

Deadline : 01 Aug 2022

Other Information

Notice Type : Tender

TOT Ref.No.: 47830797

Document Ref. No. : 564276-2020

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : AOK NORDWEST - THE HEALTH INSURANCE FUND
Address: Copenhagener Str. 1
Town: Dortmund
NUTS code: DEA - NORTH RHINE-WESTPHALIA
Postal Code: 44269
Germany
Email :openhouse@nw.aok.de
URL :www.aok.de

Tender Details

Document Type: Corrigendum / Additional information (Please refer tender document)

Title: Open house contracts for several active ingredients / combinations of active ingredients

Reference Number: 2020-09-10-NW-KRA-Open House

Contract Type: Supplies

Description: The subject of this publication is the conclusion of contracts in accordance with Section 130a (8) SGB V for the following active ingredients / active ingredient combinations within the framework of a so-called open house procedure:
Active ingredient ATC code

- Atazanavir J05AE08,

- Calcium carbonate & colecalciferol A12AX01,

- Certolizumab L04AB05,

- Colecalciferol A11CC05, USA
- Etanercept L04AB01,

- Fosfomycin J01XX01,

- Golimumab L04AB06,

- Lopinavir & Ritonavir J05AR10,

- Multi-enzymes (lipase, protease etc.) A09AA02,

- Posaconazole J02AC04,

- Ritonavir J05AE03,

- Tacrolimus L04AD02.

All suitable and interested pharmaceutical companies or associations of pharmaceutical companies will conclude a discount agreement in accordance with Section 130a (8) SGB V on the above-mentioned active ingredients / active ingredient combinations ...

Documents

 Tender Notice